Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.70 -0.15 (-5.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kalaris Therapeutics (KLRS) Invested Capital (2024 - 2025)

Updated

Kalaris Therapeutics (KLRS) reported Invested Capital of $78.81 million for Q4 2025, compared with -$77.08 million a year earlier and up 88.3% from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Invested Capital (2024 - 2025) Analysis & Trends

Dating back to Q4 2024, Kalaris Therapeutics' Invested Capital record includes 5 quarters.

  • By year, Invested Capital came in at -$77.08 million in FY2024.
  • Per Business Quant data, the three quarters before Q4 2025 came in at $41.87 million (Q3 2025), $53.12 million (Q2 2025) and $63.87 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 Kalaris Therapeutics 67.84 Mn 67.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 78.81 Mn
Sep 30, 2025 41.87 Mn
Jun 30, 2025 53.12 Mn
Mar 31, 2025 63.87 Mn
Dec 31, 2024 -77.08 Mn
API Access

Kalaris Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=KLRS&period=max&api_key=YOUR_API_KEY